Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - paul+sanberg
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Mecamylamine as a Therapeutic Agent for SARS-CoV-2
Advantages: A new method of treating severe acute respiratory syndrome (SARS-CoV-2) Mecamylamine, a nicotinic receptor antagonist, blocks virus and nAChR receptor binding and decreases SARS-COV-2 replication in virus-infected Calu-3 cells Mecamylamine decreases cytokine expression in MHV4-infected IMG cells and manages inflammatory conditions Mecamylamine...
Published: 9/24/2024
|
Inventor(s):
Paul Sanberg
,
Christian Brechot
Keywords(s):
Respiratory Diseases Treatment
Category(s):
Technology Classifications > Medical > Infectious Diseases
Stem Cells and Growth Factors for Treatment of CNS Diseases
Competitive Advantages Decreased cell loss Reduction of inflammation Increased neuroregeneration Summary USF researchers have assessed if human umbilical cord blood cells (hUCBCs)transplantation combined with the growth factor G-CSF afforded enhanced neuroprotection in an animal model of moder-ate TBI in the long term. Synergistic...
Published: 8/26/2023
|
Inventor(s):
Paul Sanberg
,
Cesario Borlongan
Keywords(s):
Category(s):
Technology Classifications > Medical > Neuroscience
,
Technology Classifications > Medical